Star Lake Bioscience Co (SHSE:600866) Debt-to-Equity : 0.55 (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Debt-to-Equity?

Star Lake Bioscience Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥2,591 Mil. Star Lake Bioscience Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥1,705 Mil. Star Lake Bioscience Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥7,835 Mil. Star Lake Bioscience Co's debt to equity for the quarter that ended in Mar. 2024 was 0.55.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Star Lake Bioscience Co's Debt-to-Equity or its related term are showing as below:

SHSE:600866' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.17 Med: 0.39 Max: 1.14
Current: 0.55

During the past 13 years, the highest Debt-to-Equity Ratio of Star Lake Bioscience Co was 1.14. The lowest was 0.17. And the median was 0.39.

SHSE:600866's Debt-to-Equity is ranked worse than
76.85% of 1080 companies
in the Biotechnology industry
Industry Median: 0.145 vs SHSE:600866: 0.55

Star Lake Bioscience Co Debt-to-Equity Historical Data

The historical data trend for Star Lake Bioscience Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Debt-to-Equity Chart

Star Lake Bioscience Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.23

0.24

1.14

0.65

0.56

Star Lake Bioscience Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.76	0.66	0.55	0.56	0.55

Competitive Comparison of Star Lake Bioscience Co's Debt-to-Equity

For the Biotechnology subindustry, Star Lake Bioscience Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Star Lake Bioscience Co's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Star Lake Bioscience Co's Debt-to-Equity falls into.

Star Lake Bioscience Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Star Lake Bioscience Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2450.11	+	1760.667)	/	7561.695
	=	0.56

Star Lake Bioscience Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2590.574	+	1705.445)	/	7835.337
	=	0.55

Star Lake Bioscience Co (SHSE:600866) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Star Lake Bioscience Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Star Lake Bioscience Co (SHSE:600866) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060

Website

http://www.starlake.com.cn

Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines